[HTML][HTML] Lung cancer immunotherapy: progress, pitfalls, and promises
A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Nano delivery of chemotherapeutic ICD inducers for tumor immunotherapy
Immunogenic cell death (ICD, also known as immunogenic apoptosis) of malignant cells is
confirmed to activate the host immune system to prevent, control, and eliminate tumors …
confirmed to activate the host immune system to prevent, control, and eliminate tumors …
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch… - European journal of …, 2021 - Wiley Online Library
The third edition of Flow Cytometry Guidelines provides the key aspects to consider when
performing flow cytometry experiments and includes comprehensive sections describing …
performing flow cytometry experiments and includes comprehensive sections describing …
ImmuCellAI-mouse: a tool for comprehensive prediction of mouse immune cell abundance and immune microenvironment depiction
Motivation Immune cells are important components of the immune system and are crucial for
disease initiation, progression, prognosis and survival. Although several computational …
disease initiation, progression, prognosis and survival. Although several computational …
[HTML][HTML] The past, present, and future of breast cancer models for nanomedicine development
P Boix-Montesinos, PM Soriano-Teruel… - Advanced drug delivery …, 2021 - Elsevier
Even given recent advances in nanomedicine development of breast cancer treatment in
recent years and promising results in pre-clinical models, cancer nanomedicines often fail at …
recent years and promising results in pre-clinical models, cancer nanomedicines often fail at …
[HTML][HTML] Promising applications of tumor spheroids and organoids for personalized medicine
Simple Summary Presently, the investigation of the tumor is carried out using different
models. One of the promising areas is the creation of 3D tumor models, such as spheroids …
models. One of the promising areas is the creation of 3D tumor models, such as spheroids …
[HTML][HTML] Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
MA Heinrich, AMRH Mostafa, JP Morton… - Advanced drug delivery …, 2021 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive type of cancer with
an overall survival rate of less than 7-8%, emphasizing the need for novel effective …
an overall survival rate of less than 7-8%, emphasizing the need for novel effective …
[HTML][HTML] Adoptive immunotherapy beyond CAR T-cells
Simple Summary The aging of the world population leads to a constant increase of cancer-
related morbidity and mortality. Treatment of late-stage tumors has become a significant …
related morbidity and mortality. Treatment of late-stage tumors has become a significant …
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
Syngeneic mouse models are tumors derived from murine cancer cells engrafted on
genetically identical mouse strains. They are widely used tools for studying tumor immunity …
genetically identical mouse strains. They are widely used tools for studying tumor immunity …
[HTML][HTML] Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
TI Maulana, E Kromidas, L Wallstabe… - Advanced Drug Delivery …, 2021 - Elsevier
The advances in cancer immunotherapy come with several obstacles, limiting its
widespread use and benefits so far only to a small subset of patients. One of the underlying …
widespread use and benefits so far only to a small subset of patients. One of the underlying …